Sort
48,018 grants matching “immunotherapy”
Tailoring AAV Vectors for Glioma Immunotherapy
$362,588Ou Cao · University Of Florida · R01 · FY2010 · AI
Lung Cancer Vaccine
$362,579Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · U54 · FY2022 · CA
A novel T-cell subset able to kill relapsed cancers
$362,569Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
$362,569Bin He · Baylor College Of Medicine · R01 · FY2017 · CA
Immunotherapy of human bladder cancer
$362,569Lawrence Fong · University Of California, San Francisco · R01 · FY2017 · CA
Immunotherapy of human bladder cancer
$362,569Lawrence Fong · University Of California, San Francisco · R01 · FY2015 · CA
A novel T-cell subset able to kill relapsed cancers
$362,569Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
Immunotherapy of human bladder cancer
$362,569Lawrence Fong · University Of California, San Francisco · R01 · FY2016 · CA
Immunotherapy of human bladder cancer
$362,569Lawrence Fong · University Of California, San Francisco · R01 · FY2018 · CA
beta-Amyloid Antibodies with Specific Proteolytic Activity
$362,558Sudhir Paul · University Of Texas Hlth Sci Ctr Houston · R01 · FY2008 · AG
Mechanisms of HSK amelioration
$362,500Patrick M Stuart · Saint Louis University · R01 · FY2011 · EY
Myeloid-Derived Regulatory Cells in Asthma
$362,490Jessy Satyadas Deshane · University Of Alabama At Birmingham · R01 · FY2017 · HL
Myeloid-Derived Regulatory Cells in Asthma
$362,490Jessy Satyadas Deshane · University Of Alabama At Birmingham · R01 · FY2018 · HL
Myeloid-Derived Regulatory Cells in Asthma
$362,490Jessy Satyadas Deshane · University Of Alabama At Birmingham · R01 · FY2016 · HL
Myeloid-Derived Regulatory Cells in Asthma
$362,490Jessy Satyadas Deshane · University Of Alabama At Birmingham · R01 · FY2020 · HL
Myeloid-Derived Regulatory Cells in Asthma
$362,490Jessy Satyadas Deshane · University Of Alabama At Birmingham · R01 · FY2019 · HL
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C
$362,472Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2009 · CA
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$362,472Ling Gao · Southern California Inst For Res/Educ · R01 · FY2024 · CA
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
$362,434David M. Ashley · Duke University · R01 · FY2024 · CA
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$362,428Jordan Scott Orange · Columbia University Health Sciences · R01 · FY2018 · AI
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$362,378Lieping Chen · Yale University · P50 · FY2021 · CA
Targeted Nanomedicines with Synergistic Chemotherapeutics to Enhance Immunotherapy of Metastatic Colorectal Cancer
$362,362Wenbin Lin · University Of Chicago · R01 · FY2022 · CA
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
$362,340David E Fisher · Massachusetts General Hospital · R01 · FY2019 · CA
Project 1: Employing CD11b-Agonists to Render PDAC Responsive to Immunotherapy
$362,331David G Denardo · Washington University · P50 · FY2024 · CA
Regulation of T Cell Activity During Chronic Infections
$362,324Allan J Zajac · University Of Alabama At Birmingham · R56 · FY2014 · AI